Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer

International Journal of Radiation Oncology Biology Physics

Volumn 90, Issue 4, 2014, Pages 911-917

  Morganti, Alessio G ^a,b   Falconi, Massimo ^c   Van Stiphout, Ruud G P M ^d   Mattiucci, Gian Carlo ^a   Alfieri, Sergio ^a   Calvo, Felipe A ^e   Dubois, Jean Bernard ^f   Fastner, Gerd ^g   Herman, Joseph M ^h   Maidment, Bert W ⁱ   Miller, Robert C ^j   Regine, William F ^k   Reni, Michele ^l   Sharma, Navesh K ^k   Ippolito, Edy ^m   Valentini, Vincenzo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b General Oncology Unit   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f CENTRE VAL D AURELLE   (France)

^g PARACELSUS MEDICAL UNIVERSITY   (Austria)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

^j MAYO CLINIC   (United States)

^k UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^l SAN RAFFAELE HOSPITAL   (Italy)

^m UNIVERSITY CAMPUS BIO MEDICO   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHEMORADIOTHERAPY; CHEMOTHERAPY; DISEASE CONTROL; DISEASES; MULTIVARIANT ANALYSIS; PATIENT MONITORING; RADIOTHERAPY; SURGERY;

CHEMORADIATION THERAPIES; CONCURRENT CHEMOTHERAPY; INTRAOPERATIVE RADIATION THERAPIES; METHODS AND MATERIALS; MULTI VARIATE ANALYSIS; PANCREATIC ADENOCARCINOMA; POSITIVE LYMPH NODES; POSTOPERATIVE RADIATION THERAPY;

DIAGNOSIS;

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CONFIDENCE INTERVAL; FEMALE; HUMAN; INTRAOPERATIVE RADIOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; RADIATION DOSE; RETROSPECTIVE STUDY; TUMOR INVASION; TUMOR VOLUME; ADENOCARCINOMA; ANALYSIS OF VARIANCE; CARCINOMA; CLINICAL TRIAL; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; CONFIDENCE INTERVALS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84908200911     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.07.024     Document Type: Article

References (35)

1. M. Kayahara, T. Nagakawa, and T. Ohta Analysis of paraaortic lymph node involvement in pancreatic carcinoma: A significant indication for surgery? Cancer 85 1999 583 590
2. S. Hishinuma, Y. Ogata, and M. Tomikawa Patterns of recurrence after curative resection of pancreatic cancer based on autopsy findings J Gastrointest Surg 10 2006 511 518
3. M.H. Kalser, and S.S. Ellenberg Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 1985 899 903
4. Gastrointestinal Tumor Study Group (GITSG) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer Cancer 59 1987 2006 2010
5. C.J. Yeo, R.A. Abrams, and L.B. Grochow Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival - a prospective, single-institution experience Ann Surg 225 1997 621 633
6. J.H. Klinkenbijl, J. Jeekel, and T. Sahmoud Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group Ann Surg 230 1999 776 782
7. J.P. Neoptolemos, J.A. Dunn, and D.D. Stocken Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomized controlled trial Lancet 358 2001 1576 1585
8. J.P. Neoptolemos, D.D. Stocken, and H. Friess A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200 1210
9. M. Garofalo, T. Flannery, and W. Regine The case for adjuvant chemoradiation for pancreatic cancer Best Pract Res Clin Gastroenterol 20 2006 403 416
10. V.J. Picozzi, R.A. Kozarek, and L.W. Traverso Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma Am J Surg 185 2003 476 480
11. A.M. Allen, M.M. Zalupski, and J.M. Robertson Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full dose gemcitabine Int J Radiat Oncol Biol Phys 59 2004 1461 1467
12. C.C. Hsu, J.M. Herman, and M.M. Corsini Adjuvant chemoradiation for pancreatic adenocarcinoma: The Johns Hopkins Hospital-Mayo Clinic collaborative study Ann Surg Oncol 17 2010 981 990
13. M.M. Corsini, R.C. Miller, and M.G. Haddock Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: The Mayo Clinic experience (1975-2005) J Clin Oncol 26 2008 3511 3516
14. J.M. Herman, M.J. Swartz, and C.C. Hsu Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: Results of a large, prospectively collected database at the Johns Hopkins Hospital J Clin Oncol 26 2008 3503 3510
15. V. Valentini, A.G. Morganti, and G. Macchia Intraoperative radiation therapy in resected pancreatic carcinoma: Long-term analysis Int J Radiat Oncol Biol Phys 70 2008 1094 1099
16. A.G. Morganti, V. Valentini, and G. Macchia Adjuvant radiotherapy in resectable pancreatic carcinoma Eur J Surg Oncol 28 2002 523 530
17. F.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations Am J Stat Assoc 53 1958 457 481
18. R. Peto, and J. Peto Asymptotically efficient rank invariant procedures J R Stat Soc 135 1972 185 207
19. D.R. Cox Regression model and life tables J R Stat Soc Series B34 1972 187 220
20. M.C. Garofalo, W.F. Regine, and M.T. Tan On statistical reanalysis, the EORTC trial is a positive trial for adjuvant chemoradiation in pancreatic cancer Ann Surg 244 2006 332 333
21. M.C. Koshy, J.C. Landry, and S.X. Cavanaugh A challenge to the therapeutic nihilism of ESPAC-1 Int J Radiat Oncol Biol Phys 61 2005 965 966
22. C.H. Crane, E. Ben-Josef, and W. Small Chemotherapy for pancreatic cancer N Engl J Med 350 2004 2713 2715
23. R.A. Abrams, K.D. Lillemoe, and S. Piantadosi Continuing controversy over adjuvant therapy of pancreatic cancer Lancet 358 2001 1565 1566
24. D.B. Evans, K.R. Hess, and P.W. Pisters ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas Ann Surg 236 2002 694 696
25. M.A. Choti Adjuvant therapy for pancreatic cancer - the debate continues N Engl J Med 350 2004 1249 1251
26. W.F. Regine, K.A. Winter, and R.A. Abrams Fluorouracil vs. gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial JAMA 299 2008 1019 1026
27. A. Khanna, G.R. Walker, and A.S. Livingstone Is adjuvant 5-F U-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question J Gastrointest Surg 10 2006 689 697
28. N.B. Merchant, J. Rymer, and E.A. Koehler Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: Who really benefits? J Am Coll Surg 208 2009 829 838
29. J.E. Lim, M.W. Chien, and C.C. Earle Prognostic factors following curative resection for pancreatic adenocarcinoma: A population based, linked database analysis of 396 patients Ann Surg 237 2003 74 85
30. L. Hazard, J.D. Tward, and A. Szabo Radiation therapy is associated with improved survival in patients with pancreatic adenocarcinoma: Results of a study from the Surveillance, Epidemiology, and End Results (SEER) registry data Cancer 15 2007 2191 2201
31. K.A. Vanderveen, S.L. Chen, and D. Yin Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysis Cancer 115 2009 2420 2429
32. T.P. Mc Dade, J.S. Hill, and J.P. Simons A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma Cancer 116 2010 3257 3266
33. H. Oettle, S. Post, and P. Neuhaus Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial JAMA 297 2007 267 277
34. A.S. Rosemurgy, M. Bloomston, and F.M. Serafini Frequency with wich surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality J Gastrointest Surg 5 2001 21 26
35. R.A. Abrams, K.A. Winter, and W.F. Regine Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704 - a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas Int J Radiat Oncol Biol Phys 82 2012 809 816